Skip to main content

Closed

RNTX: Rein Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-120.9%

Financially safe

Stretched

Debt / equity0.42×

Interest coverage0.0×

Current ratio0.40×

Rein Therapeutics Inc.

RNTXNASDAQ Global Market·USD·Closed

Rein Therapeutics Inc.

RNTXNASDAQ·USD·Closed

$0.74

−3.98%

$0.74

−$0.03 (3.98%)

52W Range

1thpctl

Volume

0.45×avg

Mkt Cap

20.61MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.45×avg

Market Cap

20.61MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings